Cross Linking for Treatment of Corneal Infection

Price Vision Group30 enrolled

Overview

This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Infectious Keratitis

Interventions

riboflavinDRUG

riboflavin 0.1% is applied every 2 minutes for 30 minutes

UVX LightDEVICE

UVX 365 nm wavelength light source is applied with continued application of riboflavin 0.1%

Eligibility

Sex: ALLMin age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of infectious keratitis Exclusion Criteria: * corneal ulcer that has perforated * corneal ulcer that has produced a descemetocele * women who are pregnant or breastfeeding * patients who are immunocompromised or unwilling or unable to comply with a medication regimen

Locations (1)

Price Vision Group

Indianapolis, Indiana, United States

Outcomes

Primary Outcomes

Time to Re-epithelialization

Time frame: Day 1, day 2, day 3, day 4, day 5, day 6, day 7, week 2, and subsequent weekly assessments until re-epithelialization is complete

Secondary Outcomes

Time to Resolution of Stromal Infiltration

Time frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7, week 2, and subsequent weekly assessments until infiltrate is completely resolved

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.